Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Predictors of excessive short-acting β2-agonist use and asthma exacerbations: a retrospective analysis of a Polish prescription database.
Kupczyk M, Barg W, Bochenek G, Brożek G, D Browiecki P, Brzostek D, D Browski A, Dobek R, Gawlik R, Kucharczyk A, Kupryś-Lipińska I, Mastalerz-Migas A, Kowalski ML. Kupczyk M, et al. Among authors: dobek r. Postepy Dermatol Alergol. 2023 Dec;40(6):790-797. doi: 10.5114/ada.2023.133454. Epub 2024 Jan 8. Postepy Dermatol Alergol. 2023. PMID: 38282873 Free PMC article.
A new formulation of fluticasone propionate/salmeterol in a metered-dose inhaler (MDI HFA) allows for the reduction of a daily dose of corticosteroid and provides optimal asthma control - A randomized, multi-center, non-inferiority, phase IV clinical study.
Kupczyk M, Majak P, Kuna P, Asankowicz-Bargiel B, Barańska E, Dobek R, Garbicz S, Jerzyńska J, Latos A, Machowiak W, Majorek-Olechowska B, Olech-Cudzik A, Poziomkowska-Gęsicka I, Rulewicz-Warniełło M, Świderska A, Tarnowski M, Kopyto P. Kupczyk M, et al. Among authors: dobek r. Respir Med. 2021 Jan;176:106274. doi: 10.1016/j.rmed.2020.106274. Epub 2020 Nov 29. Respir Med. 2021. PMID: 33276251 Free article. Clinical Trial.
Results of a Phase 2b Trial With GB001, a Prostaglandin D2 Receptor 2 Antagonist, in Moderate to Severe Eosinophilic Asthma.
Moss MH, Lugogo NL, Castro M, Hanania NA, Ludwig-Sengpiel A, Saralaya D, Dobek R, Ojanguren I, Vyshnyvetskyy I, Bruey JM, Osterhout R, Tompkins CA, Dittrich K, Raghupathi K, Ortega H; LEDA Investigators. Moss MH, et al. Among authors: dobek r. Chest. 2022 Aug;162(2):297-308. doi: 10.1016/j.chest.2022.02.038. Epub 2022 Mar 3. Chest. 2022. PMID: 35248549 Free article. Clinical Trial.
The G/G genotype of transforming growth factor beta 1 (TGF-beta1) single nucleotide (+915G/C) polymorphism coincident with other host and environmental factors is associated with irreversible bronchoconstriction in asthmatics.
Liebhart J, Polak M, Dabrowski A, Dobek R, Liebhart E, Dor-Wojnarowska A, Barg W, Kulczak A, Medrala W, Gladysz U, Lange A. Liebhart J, et al. Among authors: dobek r. Int J Immunogenet. 2008 Dec;35(6):417-22. doi: 10.1111/j.1744-313X.2008.00771.x. Int J Immunogenet. 2008. PMID: 19046298
Production of leukotriene C4 by peripheral blood leukocytes stimulated with anti-fcepsilonRI antibody, PMA, and fMLP does not correlate with irreversible airway obstruction in asthmatics.
Liebhart J, Medrala W, Gladysz U, Barg W, Liebhart E, Dobek R, Dor A, Kulczak A, Gogolewski G, Bigda A, Panaszek B. Liebhart J, et al. Among authors: dobek r. J Investig Allergol Clin Immunol. 2007;17(1):1-5. J Investig Allergol Clin Immunol. 2007. PMID: 17323856 Free article.
27 results